Advertisement

Click here for more guidelines.

 
 




CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2008; 52:559-566, doi:10.1016/j.jacc.2008.04.047
© 2008 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow View Related Story on Cardiosmart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (19)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Olivotto, I.
Right arrow Articles by Maron, B. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Olivotto, I.
Right arrow Articles by Maron, B. J.
Related Collections
Right arrowRelated Articles

CLINICAL RESEARCH: HYPERTROPHIC CARDIOMYOPATHY

Assessment and Significance of Left Ventricular Mass by Cardiovascular Magnetic Resonance in Hypertrophic Cardiomyopathy

Iacopo Olivotto, MD*,*, Martin S. Maron, MD§, Camillo Autore, MD{dagger}, John R. Lesser, MD{ddagger}, Luigi Rega, MD*, Giancarlo Casolo, MD*, Marcello De Santis, MD{dagger}, Giovanni Quarta, MD{dagger}, Stefano Nistri, MD*, Franco Cecchi, MD*, Carol J. Salton, BA||, James E. Udelson, MD§, Warren J. Manning, MD|| and Barry J. Maron, MD{ddagger}

* Regional Referral Center for Myocardial Diseases and Radiology Unit, Azienda Ospedaliera Universitaria Careggi, Florence, Italy
{dagger} Cardiology and Radiology Units, Ospedale Sant'Andrea, Università di Roma "La Sapienza," Rome, Italy
{ddagger} Hypertrophic Cardiomyopathy Center, Minneapolis Heart Institute Foundation, Minneapolis, Minnesota
§ Division of Cardiology, Tufts-New England Medical Center, Boston, Massachusetts
|| Department of Medicine (Cardiovascular Division) and Radiology, Beth Israel Deaconess Hospital and Harvard Medical School, Boston, Massachusetts.

Manuscript received January 17, 2008; revised manuscript received April 17, 2008, accepted April 28, 2008.

* Reprint requests and correspondence: Dr. Iacopo Olivotto, Centro di Riferimento per le Cardiomiopatie, Cardiologia San Luca, Azienda Ospedaliera Universitaria Careggi, Viale Pieraccini 19, 50134 Firenze, Italy. (Email: olivottoi{at}ao-careggi.toscana.it).

Objectives: Our aim was to assess the distribution and clinical significance of left ventricular (LV) mass in patients with hypertrophic cardiomyopathy (HCM).

Background: Hypertrophic cardiomyopathy is defined echocardiographically by unexplained left ventricular wall thickening. Left ventricular mass, quantifiable by modern cardiovascular magnetic resonance techniques, has not been systematically assessed in this disease.

Methods: In 264 HCM patients (age 43 ± 18 years; 75% men), LV mass by cardiovascular magnetic resonance was measured, indexed by body surface area, and compared with that in 606 healthy control subjects.

Results: The LV mass index in HCM patients significantly exceeded that of control subjects (104 ± 40 g/m2 vs. 61 ± 10 g/m2 in men and 89 ± 33 g/m2 vs. 47 ± 7 g/m2 in women; both p < 0.0001). However, values were within the normal range (≤ mean +2 SDs for control subjects) in 56 patients (21%), and only mildly increased (mean +2 to 3 SDs) in 18 (16%). The LV mass index showed a modest relationship to maximal LV thickness (r2 = 0.38; p < 0.001), and was greater in men (104 ± 40 g/m2 vs. 89 ± 33 g/m2 in women; p < 0.001) and in patients with resting outflow obstruction (121 ± 43 g/m2 vs. 96 ± 37 g/m2 in nonobstructives; p < 0.001). During a 2.6 ± 0.7-year follow-up, markedly increased LV mass index proved more sensitive in predicting outcome (100%, with 39% specificity), whereas maximal wall thickness >30 mm was more specific (90%, with 41% sensitivity).

Conclusions: In distinction to prior perceptions, LV mass index was normal in about 20% of patients with definite HCM phenotype. Therefore, increased LV mass is not a requirement for establishing the clinical diagnosis of HCM. The LV mass correlated weakly with maximal wall thickness, and proved more sensitive in predicting outcome.

Key Words: hypertrophic cardiomyopathy • cardiac magnetic resonance • left ventricular mass • hypertrophy • outcome

Abbreviations and Acronyms
  BSA = body surface area
  CMR = cardiovascular magnetic resonance
  HCM = hypertrophic cardiomyopathy
  LV = left ventricle/ventricular
  OR = odds ratio


Related Articles

Hypertrophic Cardiomyopathy: Cardiac Magnetic Resonance Imaging Changes the Paradigm
Nathaniel Reichek and Dipti Gupta
J. Am. Coll. Cardiol. 2008 52: 567-568. [Full Text] [PDF]

Inside This Issue of JACC
J. Am. Coll. Cardiol. 2008 52: A33-A34. [Full Text] [PDF]



This article has been cited by other articles:


Home page
Eur Heart J Cardiovasc ImagingHome page
A. Barbieri, F. Bursi, F. Mantovani, C. Valenti, M. Quaglia, E. Berti, M. Marino, and M. G. Modena
Left ventricular hypertrophy reclassification and death: application of the Recommendation of the American Society of Echocardiography/European Association of Echocardiography
Eur Heart J Cardiovasc Imaging, January 1, 2012; 13(1): 109 - 117.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll Cardiol ImgHome page
A. C. Y. To, A. Dhillon, and M. Y. Desai
Cardiac Magnetic Resonance in Hypertrophic Cardiomyopathy
J. Am. Coll. Cardiol. Img., October 1, 2011; 4(10): 1123 - 1137.
[Abstract] [Full Text] [PDF]


Home page
Circ Cardiovasc ImagingHome page
M. Y. Desai, S. R. Ommen, W. J. McKenna, H. M. Lever, and P. M. Elliott
Imaging Phenotype Versus Genotype in Hypertrophic Cardiomyopathy
Circ Cardiovasc Imaging, March 1, 2011; 4(2): 156 - 168.
[Full Text] [PDF]


Home page
Eur Heart J Cardiovasc ImagingHome page
A. T. Turer, Z. Samad, A. M. Valente, M. A. Parker, B. Hayes, R. J. Kim, J. Kisslo, and A. Wang
Anatomic and clinical correlates of septal morphology in hypertrophic cardiomyopathy
Eur Heart J Cardiovasc Imaging, February 1, 2011; 12(2): 131 - 139.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
M. Salerno and C. M. Kramer
Prognosis in Hypertrophic Cardiomyopathy With Contrast-Enhanced Cardiac Magnetic Resonance: The Future Looks Bright
J. Am. Coll. Cardiol., September 7, 2010; 56(11): 888 - 889.
[Full Text] [PDF]


Home page
Circ Cardiovasc ImagingHome page
R. Gebker, J. G. Mirelis, C. Jahnke, T. Hucko, R. Manka, A. Hamdan, B. Schnackenburg, E. Fleck, and I. Paetsch
Influence of Left Ventricular Hypertrophy and Geometry on Diagnostic Accuracy of Wall Motion and Perfusion Magnetic Resonance During Dobutamine Stress
Circ Cardiovasc Imaging, September 1, 2010; 3(5): 507 - 514.
[Abstract] [Full Text] [PDF]


Home page
Heart AsiaHome page
F. Alpendurada, J. Wong, and D. J. Pennell
Practical applications of cardiovascular magnetic resonance
Heart Asia, July 5, 2010; 1(1): 31 - 37.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
D. J. Pennell
Cardiovascular Magnetic Resonance
Circulation, February 9, 2010; 121(5): 692 - 705.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
T. D. Karamitsos, J. M. Francis, S. Myerson, J. B. Selvanayagam, and S. Neubauer
The Role of Cardiovascular Magnetic Resonance Imaging in Heart Failure
J. Am. Coll. Cardiol., October 6, 2009; 54(15): 1407 - 1424.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
M. S. Maron, B. J. Maron, C. Harrigan, J. Buros, C. M. Gibson, I. Olivotto, L. Biller, J. R. Lesser, J. E. Udelson, W. J. Manning, et al.
Hypertrophic Cardiomyopathy Phenotype Revisited After 50 Years With Cardiovascular Magnetic Resonance
J. Am. Coll. Cardiol., July 14, 2009; 54(3): 220 - 228.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
C. J. McLeod, M. J. Ackerman, R. A. Nishimura, A. J. Tajik, B. J. Gersh, and S. R. Ommen
Outcome of Patients With Hypertrophic Cardiomyopathy and a Normal Electrocardiogram
J. Am. Coll. Cardiol., July 14, 2009; 54(3): 229 - 233.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
A. N. DeMaria, O. Ben-Yehuda, J. J. Bax, G. K. Feld, B. H. Greenberg, W. Y.W. Lew, J. A.C. Lima, A. S. Maisel, S. M. Narayan, D. J. Sahn, et al.
Highlights of the Year in JACC 2008
J. Am. Coll. Cardiol., January 27, 2009; 53(4): 373 - 398.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
Z.-Z. Song
Left Ventricular Mass and the Outcome of Patients With Hypertrophic Cardiomyopathy
J. Am. Coll. Cardiol., January 27, 2009; 53(4): 399 - 399.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
I. Olivotto, M. S. Maron, F. Cecchi, and B. J. Maron
Reply
J. Am. Coll. Cardiol., January 27, 2009; 53(4): 399 - 399.
[Full Text] [PDF]


Home page
J Am Coll Cardiol ImgHome page
B. J. Maron and C. Y. Ho
Hypertrophic cardiomyopathy without hypertrophy: an emerging pre-clinical subgroup composed of genetically affected family members.
J. Am. Coll. Cardiol. Img., January 1, 2009; 2(1): 65 - 68.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
W.H. W. Tang and G. S. Francis
The Year in Heart Failure
J. Am. Coll. Cardiol., November 11, 2008; 52(20): 1671 - 1678.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
N. Reichek and D. Gupta
Hypertrophic Cardiomyopathy: Cardiac Magnetic Resonance Imaging Changes the Paradigm
J. Am. Coll. Cardiol., August 12, 2008; 52(7): 567 - 568.
[Full Text] [PDF]



 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement